Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAFT-600 in tinea pedis
NCT01289015Phase 3Completed
- Sponsor
- Merz
- Start
- Feb 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of naftifine organogel (MediQuest Therapeutics) in tinea pedis, sponsored by Merz. Started Feb 2011; status: completed.
02
Drugs
naftifine organogel (MediQuest Therapeutics)
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT01289015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289015.